Targeting a protein that leukemia cells use to stay alive may be the key to fighting drug-resistant leukemia, a discovery that may make cancer drugs more powerful and help doctors formulate drug cocktails to cure more children of leukemia, a team led by UCSF researchers reports.
April 11, 2011
Solving part of a medical mystery, researchers at UCSF have established a link between molecules found in an inflamed pancreas and the early formation of pancreatic cancer – a discovery that may help scientists identify new ways to detect, monitor and treat this deadly disease.
April 04, 2011
Frank McCormick, director of the UCSF Helen Diller Family Comprehensive Cancer Center, discusses the complexities and challenges of cancer in a video interview with the American Association for Cancer Research.
March 28, 2011
Calculations by researchers at UCSF and the University of California, Berkeley estimate that the cancer risk associated with one type of airport security scanners is low based on the amount of radiation these devices emit, as long as they are operated and function correctly.
March 22, 2011
Cancer research pioneer Frank McCormick has been elected the new president-elect of the American Association for Cancer Research (AACR), the world’s oldest and largest scientific organization focused on preventing and curing cancer.
February 03, 2011
UCSF Nobel laureate Elizabeth Blackburn is not ready to predict how long you will live. But she and her UCSF colleagues are exploring a feature within cells that is a kind of hourglass for aging.
February 02, 2011
Lewis Lanier, American Cancer Society Research Professor and chair of the Department of Microbiology and Immunology at UCSF, will deliver the 54th Faculty Research Lectureship in Basic Science on February 14.
January 28, 2011
UCSF is voluntarily committing to an ambitious goal for its new medical center at Mission Bay to hire a workforce averaging at least 20 percent San Francisco residents during the first year of the project.
December 15, 2010
Brain cancers are deadly more often than not, but UCSF researchers have determined that a particular genetic signature in is associated with longer survival, a discovery that may lead to better therapies for some of the deadliest brain cancers.
December 14, 2010
For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer. A UCSF-led team of scientists has identified for the first time that progenitor rather than neural stem cells underly a type of glioma called oligodendroglioma.